News and Announcements
Mosaic generated tremendous growth across its key SE Asia markets in 2019, culminating in a capital raise of US$1 MM in Q4
- Published December 16, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Key Takeaways:
- Raised US $1MM;
- Increased customer base by 3x since Dec’18;
- Doubled annual revenue
Mosaic Solutions had a tremendous 2019, culminating in raising an additional US$1 million in Q4. This increases the total amount raised to date to almost US$3 million. We launched our full product suite into the market, with an updated version of Analytics, in Q1…and have driven great customer growth since that point.
We tripled our customer base in 2019 (vs 2018) and will double annual revenue. As importantly, we are well-positioned for continued (and accelerated) growth in 2020 in our key markets across SE Asia.
About Mosaic Solutions
Mosaic Solutions is a leading provider of profit optimization solutions designed specifically for the hospitality industry. The suite of products includes data analytics, inventory management, point of sale and purchasing system. Mosaic Solutions is offered across Asia, and globally on an outsourced or reseller basis, and is headquartered in Manila, Philippines.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
